11.05.25 -- A (Partial) Vindication For Wuxi AppTec … And Global Outsourcing

In this webinar, experts will explore strategies to improve drug candidate success rates by integrating robust formulation development and predictive preclinical models. Learn how comprehensive drug characterization, in vitro/ex vivo testing, and systematic formulation approaches can identify promising candidates early, reduce development risks, and align with evolving regulatory expectations to streamline development and improve overall therapeutic outcomes. Click here to learn more.

Non-uniform density causes many tablet failures. Learn how optimizing your formulation, tablet proportions, and tooling design ensures proper de-aeration for consistent quality.

Review a commercially-ready process capable of reproducing spray-dried dispersions with less manufacturing complexity and environmental impact, and out-designing and outperforming spray drying.

Watch as Steven Facer, Adare's Vice President of Business Development EU/ROW, discusses the challenges of pediatric oral solid dose manufacturing and how to overcome them.

The ISPE's new guide addresses software for managing digital assets related to qualification, verification, validation, and compliance assurance.

Explore how Simulated Moving Bed (SMB) technology can enhance API production while overcoming common misconceptions about chromatographic purification.

Nitrosamines are a serious risk in drug products, driven by secondary amines, conducive conditions, and nitrosating agents. Understanding these factors is key to risk mitigation and patient safety.

Discover how a CDMO with integrated services enabled a botanical drug start-up to commence its Phase 1 clinical trial, paving the way for further advancement of its innovative botanical drug.

Combination therapies delivered directly to the lung by dry powder inhalants are an effective means of reducing patient burden. Read about case studies that illustrate the potential for improving care.

A pharma company sought a CMO partner with commercial manufacturing capabilities and expertise as well as exemplary quality systems to find a cost-effective process to produce the API for a new drug.

With over two decades of insourcing experience and a global footprint across 110+ client sites, PSS delivers strategic, on-site support tailored to each client’s regulatory landscape.

Liquid-filled two-piece capsules offer advantages like scalability, faster absorption, simpler packaging, and greater product stability. Learn more about their benefits in pharmaceutical development.

See why partnering with experts with experience in complex, sensitive, and potent APIs, screening for the optimal formulation, and scaling up efficiently is vital for successful trials and commercialization.

Consider our cutting-edge services in powder blending, encapsulation, tablet compression, and on-site laboratory testing that meet the highest standards to ensure exceptional quality and compliance.

As a leading CDMO, we specialize in the development and manufacturing of diverse dosage forms for both clinical and commercial applications, driven by a culture of innovation and commitment to quality.